Articles by Gregory M. Lucas

Injection Drug Network Characteristics Are Important Markers of HIV Risk Behavior and Lack of Viral Suppression

Cepeda, Javier A.; Solomon, Sunil S.; Srikrishnan, Aylur K.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(3):257-264, July 1st, 2017.

Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine–Naloxone: HIV Prevention Trials Network 058

Metzger, David S.; Donnell, Deborah; Celentano, David D.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(5):554-561, April 15th, 2015.